Literature DB >> 6087691

Type I familial amyloidotic polyneuropathy (Japanese type).

S Araki.   

Abstract

Our recent studies on familial amyloidotic polyneuropathy (FAP) were reviewed. Since the clinical picture of our FAP is slightly different from those of the Portuguese type, the Swedish type, and the Jewish type, structural identification of the amyloid fibril proteins should be clarified on a molecular basis. Further investigation on the effectiveness of dimethyl sulfoxide (DMSO) or a search for other useful new drugs is greatly required.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6087691     DOI: 10.1016/s0387-7604(84)80061-3

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  14 in total

1.  Assignment of the prealbumin (PALB) gene (familial amyloidotic polyneuropathy) to human chromosome region 18q11.2-q12.1.

Authors:  R S Sparkes; H Sasaki; T Mohandas; K Yoshioka; I Klisak; Y Sakaki; C Heinzmann; M I Simon
Journal:  Hum Genet       Date:  1987-02       Impact factor: 4.132

2.  Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan.

Authors:  Taro Yamashita; Mitsuharu Ueda; Yohei Misumi; Teruaki Masuda; Toshiya Nomura; Masayoshi Tasaki; Kotaro Takamatsu; Keiko Sasada; Konen Obayashi; Hirotaka Matsui; Yukio Ando
Journal:  J Neurol       Date:  2017-11-24       Impact factor: 4.849

Review 3.  Liver transplantation and new therapeutic approaches for familial amyloidotic polyneuropathy (FAP).

Authors:  Yukio Ando
Journal:  Med Mol Morphol       Date:  2005-09       Impact factor: 2.309

4.  Ocular manifestations of familial amyloidotic polyneuropathy type I: long-term follow up.

Authors:  E Ando; Y Ando; R Okamura; M Uchino; M Ando; A Negi
Journal:  Br J Ophthalmol       Date:  1997-04       Impact factor: 4.638

5.  Manifestations of transthyretin-related familial amyloidotic polyneuropathy: long-term follow-up of Japanese patients after liver transplantation.

Authors:  Yuki Ohya; Sadahisa Okamoto; Masayoshi Tasaki; Mitsuharu Ueda; Hirofumi Jono; Konen Obayashi; Kazuhisa Takeda; Hideaki Okajima; Katsuhiro Asonuma; Ryuhei Hara; Hidenobu Tanihara; Yukio Ando; Yukihiro Inomata
Journal:  Surg Today       Date:  2011-08-26       Impact factor: 2.549

6.  Identification of carriers of mutant prealbumin gene associated with familial amyloidotic polyneuropathy type I by Southern blot procedures: study of six pedigrees in the Arao district of Japan.

Authors:  M Ide; S Mita; S Ikegawa; S Maeda; K Shimada; S Araki
Journal:  Hum Genet       Date:  1986-08       Impact factor: 4.132

7.  Ocular microangiopathy in familial amyloidotic polyneuropathy, type I.

Authors:  E Ando; Y Ando; S Maruoka; Y Sakai; S Watanabe; R Yamashita; R Okamura; S Araki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

Review 8.  Familial amyloidotic polyneuropathy: protein aggregation in the peripheral nervous system.

Authors:  Maria João Saraiva; Mónica Mendes Sousa; Isabel Cardoso; Rui Fernandes
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

9.  Cerebrospinal fluid and vitreous body exposure to orally administered tafamidis in hereditary ATTRV30M (p.TTRV50M) amyloidosis patients.

Authors:  Cecilia Monteiro; Ana Martins da Silva; Natália Ferreira; Jaleh Mesgarzadeh; Marta Novais; Teresa Coelho; Jeffery W Kelly
Journal:  Amyloid       Date:  2018-07-11       Impact factor: 7.141

10.  Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met30) gene. Pathologic similarity to human familial amyloidotic polyneuropathy, type I.

Authors:  S Yi; K Takahashi; M Naito; F Tashiro; S Wakasugi; S Maeda; K Shimada; K Yamamura; S Araki
Journal:  Am J Pathol       Date:  1991-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.